Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

SABCS 2010

8 - 12 Dec 2010
St. Jude Children's Research Hospital, Memphis, United States of America

FIRST trial follow up results

Prof John Robertson - University of Nottingham, UK
FIRST trial follow up results ( Prof John Robertson - University of Nottingham, UK )
1 Feb 2011

Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast cancer

Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy
Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast cancer ( Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy )
19 Jan 2011

Molecular chaperones: cancer dependence and druggability

Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
Molecular chaperones: cancer dependence and druggability ( Prof Paul Workman - The Institute of Cancer Research, Sutton, UK )
19 Jan 2011

Exemestane potential for hormone-receptor positive, early-stage breast cancer in the adjuvant setting

Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA
Exemestane potential for hormone-receptor positive, early-stage breast cancer in the adjuvant setting ( Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA )
19 Jan 2011

Targeting of breast cancer tumour initiating cells

Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA
Targeting of breast cancer tumour initiating cells ( Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA )
19 Jan 2011

Issues with reliability in HER2 testing and avastin for metastatic breast cancer

Dr Edith Perez – Mayo Clinic, Florida, USA
Issues with reliability in HER2 testing and avastin for metastatic breast cancer ( Dr Edith Perez – Mayo Clinic, Florida, USA )
19 Jan 2011

Next generation gene sequencing

Prof Charles Perou - University of North Carolina School of Medicine, USA
Next generation gene sequencing ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
19 Jan 2011

Zoledronic acid disappointment for early breast cancer

Prof Michael Gnant - Medical University of Vienna, Austria
Zoledronic acid disappointment for early breast cancer ( Prof Michael Gnant - Medical University of Vienna, Austria )
19 Jan 2011

NeoALTTO trial results

Prof José Baselga – Massachusetts General Hospital Cancer Center, USA
NeoALTTO trial results ( Prof José Baselga – Massachusetts General Hospital Cancer Center, USA )
19 Jan 2011

Understanding stem cells to get abreast of breast cancer

Prof Geoff Lindeman – The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
Understanding stem cells to get abreast of breast cancer ( Prof Geoff Lindeman – The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia )
19 Jan 2011

Exploiting cancer stress for new therapies

Prof Garth Powis – MD Anderson Cancer Centre, Houston, USA
Exploiting cancer stress for new therapies ( Prof Garth Powis – MD Anderson Cancer Centre, Houston, USA )
19 Jan 2011

Systemic therapy for central nervous system metastases

Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
Systemic therapy for central nervous system metastases ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )
19 Jan 2011

Cancer micrometastases and circulating tumour cells in breast cancer patients

Prof Klaus Pantel - University Medical Center Hamburg-Eppendorf, Germany
Cancer micrometastases and circulating tumour cells in breast cancer patients ( Prof Klaus Pantel - University Medical Center Hamburg-Eppendorf, Germany )
19 Jan 2011

Systems biology for the clinician

Dr Dana Faratian – University of Edinburgh, UK
Systems biology for the clinician ( Dr Dana Faratian – University of Edinburgh, UK )
19 Jan 2011

Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer

Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy
Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer ( Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy )
18 Jan 2011

Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer

Prof Michael Untch - Helios Clinic, Berlin, Germany
Neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer ( Prof Michael Untch - Helios Clinic, Berlin, Germany )
18 Jan 2011

Combination therapy reduced HER2-positive breast cancers

Prof José Baselga - Massachusetts General Hospital Cancer Center, USA
Combination therapy reduced HER2-positive breast cancers ( Prof José Baselga - Massachusetts General Hospital Cancer Center, USA )
18 Jan 2011

CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer

Hui Gao - MD Anderson Cancer Center, Houston, USA
CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer ( Hui Gao - MD Anderson Cancer Center, Houston, USA )
18 Jan 2011

Denosumab delayed first skeletal-related side effect

Prof Alison Stopeck - University of Arizona, Tucson, USA
Denosumab delayed first skeletal-related side effect ( Prof Alison Stopeck - University of Arizona, Tucson, USA )
18 Jan 2011

High CTC levels predicted poor outcome in metastatic breast cancer

Prof Jean-Yves Pierga - Institut Curie and Université Paris Descartes, France
High CTC levels predicted poor outcome in metastatic breast cancer ( Prof Jean-Yves Pierga - Institut Curie and Université Paris Descartes, France )
18 Jan 2011

CTCs predicted recurrence and death in patients with early-stage breast cancer

Dr Brigitte Rack - Munich University Hospital, Germany
CTCs predicted recurrence and death in patients with early-stage breast cancer ( Dr Brigitte Rack - Munich University Hospital, Germany )
18 Jan 2011